Sara Malaca

422 total citations
19 papers, 288 citations indexed

About

Sara Malaca is a scholar working on Toxicology, Pharmacology and Clinical Psychology. According to data from OpenAlex, Sara Malaca has authored 19 papers receiving a total of 288 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Toxicology, 8 papers in Pharmacology and 7 papers in Clinical Psychology. Recurrent topics in Sara Malaca's work include Forensic Toxicology and Drug Analysis (14 papers), Cannabis and Cannabinoid Research (7 papers) and Psychedelics and Drug Studies (7 papers). Sara Malaca is often cited by papers focused on Forensic Toxicology and Drug Analysis (14 papers), Cannabis and Cannabinoid Research (7 papers) and Psychedelics and Drug Studies (7 papers). Sara Malaca collaborates with scholars based in Italy, United States and Portugal. Sara Malaca's co-authors include Francesco Paolo Busardò, Simona Pichini, Massimo Gottardi, Marilyn A. Huestis, Emilia Marchei, Eugénia Gallardo, Tiago Rosado, Mário Barroso, Alfredo Fabrizio Lo Faro and José Restolho and has published in prestigious journals such as International Journal of Molecular Sciences, Talanta and Frontiers in Pharmacology.

In The Last Decade

Sara Malaca

19 papers receiving 282 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sara Malaca Italy 11 165 101 74 63 51 19 288
Magdalene H.Y. Tang Hong Kong 8 198 1.2× 81 0.8× 116 1.6× 76 1.2× 61 1.2× 12 334
Anastasio Tini Italy 12 182 1.1× 77 0.8× 70 0.9× 41 0.7× 56 1.1× 36 345
Pietro Brunetti Italy 12 142 0.9× 116 1.1× 61 0.8× 60 1.0× 39 0.8× 23 357
Valeria Catalani Italy 11 159 1.0× 61 0.6× 118 1.6× 79 1.3× 36 0.7× 20 370
Nunzia La Maida Italy 10 181 1.1× 66 0.7× 84 1.1× 53 0.8× 37 0.7× 25 282
Silvia Graziano Italy 15 204 1.2× 126 1.2× 89 1.2× 60 1.0× 46 0.9× 43 526
P. R. Stout United States 12 201 1.2× 96 1.0× 60 0.8× 46 0.7× 66 1.3× 20 361
Luca Zamengo Italy 10 159 1.0× 90 0.9× 82 1.1× 62 1.0× 28 0.5× 24 297
Franz Dussy Switzerland 10 169 1.0× 202 2.0× 49 0.7× 49 0.8× 54 1.1× 18 408
Laurie Gheddar France 14 208 1.3× 71 0.7× 48 0.6× 46 0.7× 50 1.0× 78 504

Countries citing papers authored by Sara Malaca

Since Specialization
Citations

This map shows the geographic impact of Sara Malaca's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Malaca with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Malaca more than expected).

Fields of papers citing papers by Sara Malaca

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Malaca. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Malaca. The network helps show where Sara Malaca may publish in the future.

Co-authorship network of co-authors of Sara Malaca

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Malaca. A scholar is included among the top collaborators of Sara Malaca based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Malaca. Sara Malaca is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Malaca, Sara, Charline Bottinelli, Laurent Fanton, et al.. (2023). α-Methyltryptamine (α-MT) Metabolite Profiling in Human Hepatocyte Incubations and Postmortem Urine and Blood. Metabolites. 13(1). 92–92. 5 indexed citations
2.
Malaca, Sara, et al.. (2023). Pharmacology and toxicology of xylazine: quid novum?. PubMed. 27(15). 7337–7345. 9 indexed citations
3.
Carlier, Jérémy, Sara Malaca, Marilyn A. Huestis, et al.. (2022). Biomarkers of 4-hydroxy-N,N-methylpropyltryptamine (4-OH-MPT) intake identified from human hepatocyte incubations. Expert Opinion on Drug Metabolism & Toxicology. 18(12). 831–840. 4 indexed citations
4.
Malaca, Sara, Alfredo Fabrizio Lo Faro, Anastasio Tini, et al.. (2022). Cannabidiol, ∆9-tetrahydrocannabinol, and metabolites in human blood by volumetric absorptive microsampling and LC-MS/MS following controlled administration in epilepsy patients. Frontiers in Pharmacology. 13. 1038754–1038754. 16 indexed citations
5.
6.
Poyatos, Lourdes, Alfredo Fabrizio Lo Faro, Sara Malaca, et al.. (2022). Methylone and MDMA Pharmacokinetics Following Controlled Administration in Humans. International Journal of Molecular Sciences. 23(23). 14636–14636. 14 indexed citations
7.
8.
Montanari, Eva, Sara Malaca, Simona Zaami, et al.. (2022). 4-Hydroxy-N,N-methylpropyltryptamine (4-OH-MPT) in vitro human metabolism. Annales de Toxicologie Analytique. 34(3). S96–S96. 1 indexed citations
9.
Malaca, Sara, Massimo Gottardi, Sebastiano Barco, et al.. (2021). UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD Formulations. Pharmaceuticals. 14(7). 630–630. 19 indexed citations
10.
Malaca, Sara, Francesco Paolo Busardò, Giulio Nittari, Ascanio Sirignano, & Giovanna Ricci. (2021). Fourth Generation of Synthetic Cannabinoid Receptor Agonists: A Review onthe Latest Insights. Current Pharmaceutical Design. 28(32). 2603–2617. 19 indexed citations
11.
Pichini, Simona, Sara Malaca, Massimo Gottardi, et al.. (2020). UHPLC-MS/MS analysis of cannabidiol metabolites in serum and urine samples. Application to an individual treated with medical cannabis. Talanta. 223(Pt 2). 121772–121772. 22 indexed citations
12.
Marchei, Emilia, Sara Malaca, Silvia Graziano, et al.. (2020). Stability and Degradation Pathways of Different Psychoactive Drugs in Neat and in Buffered Oral Fluid. Journal of Analytical Toxicology. 44(6). 570–579. 12 indexed citations
13.
Malaca, Sara, et al.. (2020). Toxicology and Analysis of Psychoactive Tryptamines. International Journal of Molecular Sciences. 21(23). 9279–9279. 34 indexed citations
14.
Malaca, Sara, Jérémy Carlier, & Francesco Paolo Busardò. (2020). Advances in Forensic Toxicology. Current Pharmaceutical Design. 26(31). 3779–3780. 7 indexed citations
15.
Soares, Sofia, Tiago Rosado, Joana Gonçalves, et al.. (2019). Novel synthetic opioids – toxicological aspects and analysis. Forensic Sciences Research. 4(2). 111–140. 41 indexed citations
16.
Malaca, Sara, Francesco Paolo Busardò, Massimo Gottardi, Simona Pichini, & Emilia Marchei. (2019). Dilute and shoot ultra-high performance liquid chromatography tandem mass spectrometry (UHPLC–MS/MS) analysis of psychoactive drugs in oral fluid. Journal of Pharmaceutical and Biomedical Analysis. 170. 63–67. 34 indexed citations
17.
Malaca, Sara, Luisa Mastrobattista, Claudia Mortali, Raffaele Giorgetti, & Simona Zaami. (2019). Improvement of hair testing for Ethylglucuronide by supported liquid extraction and ultra-high performance liquid chromatography tandem mass spectrometry. Journal of Pharmaceutical and Biomedical Analysis. 174. 707–710. 3 indexed citations
18.
Malaca, Sara, Tiago Rosado, José Restolho, et al.. (2019). Determination of amphetamine-type stimulants in urine samples using microextraction by packed sorbent and gas chromatography-mass spectrometry. Journal of Chromatography B. 1120. 41–50. 22 indexed citations
19.
Rosado, Tiago, Joana Gonçalves, Ângelo Luís, et al.. (2018). Synthetic Cannabinoids in Biological Specimens: A Review of Current Analytical Methods and Sample Preparation Techniques. Bioanalysis. 10(19). 1609–1623. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Magdalene H.Y. Tang Breakdown of academic impact, for papers by Anastasio Tini Breakdown of academic impact, for papers by Pietro Brunetti Breakdown of academic impact, for papers by Valeria Catalani Breakdown of academic impact, for papers by Nunzia La Maida Breakdown of academic impact, for papers by Silvia Graziano Breakdown of academic impact, for papers by P. R. Stout Breakdown of academic impact, for papers by Luca Zamengo Breakdown of academic impact, for papers by Franz Dussy Breakdown of academic impact, for papers by Laurie Gheddar
Rankless by CCL
2026